SMO ClinPlusLTD Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Hongwei Yang
Chief executive officer
CN¥1.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 7.4% |
| Management average tenure | 8.2yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Beyond Lackluster Earnings: Potential Concerns For SMO ClinPlusLTD's (SZSE:301257) Shareholders
Nov 06
SMO ClinPlus CO.,LTD. (SZSE:301257) Held Back By Insufficient Growth Even After Shares Climb 32%
Sep 30Little Excitement Around SMO ClinPlus CO.,LTD.'s (SZSE:301257) Earnings As Shares Take 37% Pounding
Jun 06SMO ClinPlusLTD's (SZSE:301257) Promising Earnings May Rest On Soft Foundations
May 05CEO
Hongwei Yang (47 yo)
no data
Tenure
CN¥1,638,700
Compensation
Mr. Hongwei Yang is Director and General Manager of SMO ClinPlus Co., Ltd. since 2016 and serves as Founder.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | CN¥1.64m | 7.36% CN¥ 166.5m | |
| Financial Director | 8.2yrs | CN¥962.30k | 0.0082% CN¥ 185.1k | |
| Board Secretary & Non-Independent Director | no data | CN¥724.90k | 0.097% CN¥ 2.2m | |
| Deputy General Manager | 4.8yrs | CN¥807.40k | 0.0082% CN¥ 185.1k | |
| Deputy General Manager | 8.2yrs | CN¥726.90k | 0.0082% CN¥ 185.1k | |
| Deputy General Manager | 8.2yrs | CN¥850.10k | 0.0082% CN¥ 185.1k | |
| Deputy General Manager | 2.3yrs | CN¥480.10k | no data |
8.2yrs
Average Tenure
42yo
Average Age
Experienced Management: 301257's management team is seasoned and experienced (8.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | CN¥1.64m | 7.36% CN¥ 166.5m | |
| Board Secretary & Non-Independent Director | 1.8yrs | CN¥724.90k | 0.097% CN¥ 2.2m | |
| Chairman of the Board | no data | CN¥513.00k | 5.85% CN¥ 132.3m | |
| Independent Director | 4.8yrs | CN¥93.30k | no data | |
| Non-Independent Director | 1.8yrs | no data | no data | |
| Supervisor | 6.3yrs | no data | no data | |
| Non-Independent Director | 1.8yrs | no data | 0.00033% CN¥ 7.5k | |
| Chairman of the Supervisory Board | 4.8yrs | no data | 0.0076% CN¥ 170.8k | |
| Non-Independent Director | 6.3yrs | no data | no data | |
| Independent Director | 4.8yrs | CN¥100.00k | no data | |
| Independent Director | 4.8yrs | CN¥93.30k | no data | |
| Employee Representative Supervisor | 2.3yrs | no data | no data |
4.8yrs
Average Tenure
53yo
Average Age
Experienced Board: 301257's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 02:09 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SMO ClinPlus CO.,LTD. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Siao Ye | Everbright Securities Co. Ltd. |